Danaher Net Worth 2012-2026 | DHR

Interactive chart of historical net worth (market cap) for Danaher (DHR) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Danaher net worth as of September 16, 2026 is $147.18B.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sector Industry Market Cap Revenue
Medical Medical Services $147.177B $24.568B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $120.850B 12.05
HCA Healthcare (HCA) United States $91.758B 14.27
Elevance Health (ELV) United States $90.552B 14.21
Cencora (COR) United States $61.693B 18.85
Natera (NTRA) United States $50.563B 0.00
Labcorp Holdings (LH) United States $26.274B 18.52
Viatris (VTRS) United States $19.124B 6.61
Medpace Holdings (MEDP) United States $17.319B 36.37
EUROFINS SCIENT (ERFSF) Luxembourg $16.369B 0.00
DiDi Global (DIDIY) China $16.046B 176.00
Revvity (RVTY) United States $15.643B 26.20
Solventum (SOLV) United States $15.330B 12.69
ICON (ICLR) Ireland $13.204B 17.94
Charles River Laboratories (CRL) United States $13.027B 27.56
BrightSpring Health Services (BTSG) United States $11.642B 40.03
Avantor (AVTR) United States $10.443B 18.83
BioMerieux (BMXMF) France $10.192B 0.00
Caris Life Sciences,�Inc (CAI) United States $8.054B 79.17
HealthEquity (HQY) United States $7.983B 26.01
Sonic Healthcare (SKHHY) Australia $6.771B 0.00
PACS (PACS) United States $6.662B 22.39
GETINGE (GNGBY) Sweden $6.654B 18.79
CochLear (CHEOY) Australia $6.327B 0.00
MiniMed (MMED) United States $6.193B 0.00
Bausch + Lomb (BLCO) Canada $6.157B 23.28
Sotera Health (SHC) United States $5.416B 22.33
Concentras Parent (CON) United States $4.542B 22.40
Organon (OGN) United States $3.587B 4.55
GeneDx Holdings (WGS) United States $2.822B 262.89
CareDx (CDNA) United States $2.723B 309.65
Amplifon S.p.A (AMFPF) Italy $2.466B 12.74
Pediatrix Medical (MD) United States $2.169B 12.71
Alignment Healthcare (ALHC) United States $2.151B 54.58
Establishment Labs Holdings (ESTA) United States $2.130B 0.00
Progyny (PGNY) United States $2.130B 30.17
COMPASS Pathways (CMPS) United Kingdom $1.912B 0.00
Sonida Senior Living (SNDA) United States $1.907B 0.00
Surgery Partners (SGRY) United States $1.787B 68.25
Bora Pharmaceuticals, - (BORAY) Taiwan $1.695B 10.18
Freenome (FRNM) United States $1.573B 0.00
Agilon Health (AGL) United States $1.547B 0.00
Ardent Health (ARDT) United States $1.508B 8.62
InnovAge Holding (INNV) United States $1.490B 0.00
Nutex Health (NUTX) United States $1.475B 8.45
Ryman Healthcare (RYHTY) New Zealand $1.241B 0.00
Omada Health (OMDA) United States $1.204B 245.88
GoodRx Holdings (GDRX) United States $1.196B 23.27
Teladoc Health (TDOC) United States $1.195B 0.00
CryoPort (CYRX) United States $0.826B 0.00
Enhabit (EHAB) United States $0.709B 25.89
GMR Solutions (GMRS) United States $0.688B 0.00
Oncology Institute (TOI) United States $0.507B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.504B 0.00
SBC Medicals (SBC) United States $0.472B 9.77
Strata Critical Medical (SRTA) United States $0.468B 0.00
Forward Industries (FWDI) United States $0.449B 0.00
Auna S.A (AUNA) Luxembourg $0.382B 5.55
Shoulder Innovations (SI) United States $0.374B 0.00
Biodesix (BDSX) United States $0.292B 0.00
Embecta (EMBC) United States $0.288B 2.50
So-Young (SY) China $0.276B 0.00
LifeMD (LFMD) United States $0.164B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
Park Dental Partners (PARK) United States $0.098B 0.00
SkinHealth Systems (SKIN) United States $0.088B 0.00
Sera Prognostics (SERA) United States $0.079B 0.00
QDM (QDMI) Hong Kong, SAR China $0.068B 8.06
Tevogen (TVGN) United States $0.050B 0.00
DocGo (DCGO) United States $0.038B 0.00
Lifeward (LFWD) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.013B 0.00
Ainos (AIMD) United States $0.010B 0.00
Basel Medical Group (BMGL) Singapore $0.008B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
XWELL (XWEL) United States $0.008B 0.00
Aclarion (ACON) United States $0.008B 0.00
IceCure Medical (ICCM) Israel $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
20/20 Biolabs (AIDX) United States $0.006B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
Pomdoctor - (POM) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Synergy CHC (SNYR) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00